EUCRW (Eucrates Biomedical Acquisition) Other Current Payables: $0.00 Mil (As of Dec. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EUCRW Eucrates Biomedical Acquisition Corp EUCRW
22 GF Score
Price $0.00
! 2 Warning Signs
View Full Analysis

What is Eucrates Biomedical Acquisition Other Current Payables?

Eucrates Biomedical Acquisition EUCRW 22 Other Current Payables is $0.00 Mil as of Dec. 2022. GuruFocus rates EUCRW with a GF Score™ of 22/100. The stock has 2 warning signs investors should review.

Eucrates Biomedical Acquisition's Other Current Payables for the quarter that ended in Dec. 2022 was $0.00 Mil.

Eucrates Biomedical Acquisition Other Current Payables Related Terms

Eucrates Biomedical Acquisition Other Current Payables Historical Data

* Premium members only.

The historical data trend for Eucrates Biomedical Acquisition's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eucrates Biomedical Acquisition Other Current Payables Chart

Eucrates Biomedical Acquisition Annual Data
Trend Dec20 Dec21 Dec22
Other Current Payables
0.00 0.00 0.00

Eucrates Biomedical Acquisition Quarterly Data
Aug20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
EUCRW
22GF Score
Eucrates Biomedical Acquisition Corp EUCRW
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eucrates Biomedical Acquisition Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $0.00 Mil mean?
Eucrates Biomedical Acquisition (EUCRW) has a Other Current Payables of $0.00 Mil as of Dec. 2022. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Eucrates Biomedical Acquisition and its competitors.
Is Eucrates Biomedical Acquisition's Other Current Payables too high?
Eucrates Biomedical Acquisition's current Other Current Payables is $0.00 Mil. Overall, Eucrates Biomedical Acquisition has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Eucrates Biomedical Acquisition's Other Current Payables compare to FXCO and AEHA?
Eucrates Biomedical Acquisition's Other Current Payables of $0.00 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Diversified Financial Services company?
A good Other Current Payables depends on the Diversified Financial Services industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Eucrates Biomedical Acquisition and its competitors. Eucrates Biomedical Acquisition's current Other Current Payables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eucrates Biomedical Acquisition stock overvalued right now?
Eucrates Biomedical Acquisition (EUCRW) has a current Other Current Payables of $0.00 Mil. The current Other Current Payables is $0.00 Mil. Eucrates Biomedical Acquisition's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Eucrates Biomedical Acquisition (EUCRW), the current Other Current Payables is $0.00 Mil as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Eucrates Biomedical Acquisition Business Description

Address 250 West 55th Street, Suite 13D, New York, NY, USA, 10019
Eucrates Biomedical Acquisition Corp is a blank check company.
22GF Score

Get the complete analysis for EUCRW

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price